SMSPHARMA.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	166 499
Gjennomsnittsvolum	1.02M
Markedsverdi	17.58B
EPS	INR0 ( 2024-02-11 )
Neste inntjeningsdato	( INR0 ) 2024-05-21
Last Dividend	INR0.300 ( 2022-09-22 )
Next Dividend	INR0 ( N/A )
P/E	48.86
ATR14	INR0.119 (0.06%)

Volum Korrelasjon

Lang: 0.04 (neutral)

Kort: -0.91 (very strong negative)

Signal:(42.973) Neutral

SMS Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

SMS Pharmaceuticals Korrelasjon - Valuta/Råvare

0.07
( neutral )

0.23
( neutral )

0.00
( neutral )

-0.16
( neutral )

0.52
( weak )

-0.16
( neutral )

SMS Pharmaceuticals Økonomi

Annual	2022
Omsetning:	INR5.22B
Bruttogevinst:	INR1.29B (24.69 %)
EPS:	INR-0.830

FY	2022
Omsetning:	INR5.22B
Bruttogevinst:	INR1.29B (24.69 %)
EPS:	INR-0.830

FY	2022
Omsetning:	INR5.15B
Bruttogevinst:	INR1.81B (35.23 %)
EPS:	INR7.35

FY	2021
Omsetning:	INR5.61B
Bruttogevinst:	INR1.81B (32.35 %)
EPS:	INR7.39

Financial Reports:

No articles found.

SMS Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.300 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

SMS Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.32%) | Divividend Growth Potential Score: 3.48 - Decrease likely (30.32%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.200	2007-09-21
Last Dividend	INR0.300	2022-09-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	INR3.20	--
Avg. Dividend % Per Year	0.12%	--
Score	1.83	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.48
Div. Directional Score	3.73	--

Next Divdend (Est)
(2024-09-04)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

1.83

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.250	0.34%
2019	INR0.250	0.36%
2020	INR0.250	0.60%
2021	INR0.300	0.25%
2022	INR0.300	0.23%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0588	1.500	8.82	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0768	1.500	-0.258	-0.387	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3.30	1.000	9.89	9.89	[3 - 30]
operatingCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.46	2.00	6.27	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.317	1.000	8.06	8.06	[0.2 - 0.8]
operatingProfitMarginTTM	0.128	1.000	9.45	9.45	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	49.31	1.000	5.12	0	[1 - 100]
returnOnEquityTTM	0.0768	2.50	-0.166	-0.387	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
dividendYielPercentageTTM	0.143	1.500	6.43	0	[0 - 0.4]
operatingCashFlowPerShareTTM	7.46	2.00	7.51	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.443	1.500	-6.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.103	1.000	9.92	0	[0.1 - 0.5]
Total Score				3.48

SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.